Home
Conditions
Multiple Sclerosis, Relapsing-Remitting

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

464 public trials 49 recruiting studies

Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Active, not recruiting

B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis

NCT05296161

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Amsterdam UMC, location VU Amsterdam, North Holland, Netherlands

View Trial Details

Active, not recruiting

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

NCT05090371

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +10 more
Locations: Alabama Neurology Associates PC Birmingham, Alabama, United States

North Central Neurology Associates PC Cullman, Alabama, United States

Radiant Research Chandler Chandler, Arizona, United States

Arizona Neuroscience Research LLC Phoenix, Arizona, United States

View all 43 locations

View Trial Details

Active, not recruiting

A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

NCT05811416

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Local Institution - 0001 Barcelona, Spain

View Trial Details

Active, not recruiting

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

NCT06345157

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Novartis Investigative Site Ancona, AN, Italy

Novartis Investigative Site L’Aquila, AQ, Italy

Novartis Investigative Site Bari, BA, Italy

Novartis Investigative Site Bergamo, BG, Italy

View all 31 locations

View Trial Details

Active, not recruiting

Functional Outcomes From Diets in Multiple Sclerosis

NCT05327322

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Washington University St Louis, Missouri, United States

View Trial Details

Active, not recruiting

The Prevalance of Malnutrition and Its Association With Disability in Patients With Relapsing-Remitting Multiple Sclerosis

NCT07497126

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +24 more
Locations: Antalya Training and Research Hospital Antalya, Turkey (Türkiye)

View Trial Details

Active, not recruiting

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)

NCT06884579

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +13 more
Locations: Hospital Universitario Virgen de la Arrixaca Murcia, Spain

View Trial Details

Active, not recruiting

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study (Phase 1)

NCT06925022

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +8 more
Locations: Hospital Universitario Virgen de la Arrixaca Murcia, Spain

View Trial Details

Active, not recruiting

The Synergistic Effects of AIH and FES in Persons With MS

NCT06413602

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +14 more
Locations: Shirley Ryan AbilityLab Chicago, Illinois, United States

View Trial Details

Active, not recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

NCT05201638

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Neuro of Central Florida Altamonte Springs, Florida, United States

Healthcare Innovations Coral Springs, Florida, United States

Heratsi Hospital Complex 1 Yerevan, Armenia

Saint Gregory the Illuminator Medical Center Yerevan, Armenia

View all 76 locations

View Trial Details

Multiple Sclerosis, Relapsing-Remitting

Multiple Sclerosis, Relapsing-Remitting trial results

Related conditions